COVID-19 and (hydroxy)chloroquine-azithromycin combination: Should we take the risk for our patients?
Identifieur interne : 001579 ( Main/Exploration ); précédent : 001578; suivant : 001580COVID-19 and (hydroxy)chloroquine-azithromycin combination: Should we take the risk for our patients?
Auteurs : Hervé Javelot [France] ; Wissam El-Hage [France] ; Guillaume Meyer [France] ; Guillaume Becker [France] ; Bruno Michel [France] ; Coraline Hingray [France]Source :
- British journal of clinical pharmacology [ 1365-2125 ] ; 2020.
Descripteurs français
- KwdFr :
- Association de médicaments (MeSH), Azithromycine (administration et posologie), Azithromycine (effets indésirables), Chloroquine (administration et posologie), Chloroquine (effets indésirables), Facteurs de risque (MeSH), Humains (MeSH), Hydroxychloroquine (administration et posologie), Hydroxychloroquine (effets indésirables), Infections à coronavirus (traitement médicamenteux), Infections à coronavirus (épidémiologie), Pandémies (MeSH), Pneumopathie virale (traitement médicamenteux), Pneumopathie virale (épidémiologie), Syndrome du QT long (induit chimiquement), Syndrome du QT long (épidémiologie), Troubles mentaux (complications).
- MESH :
- administration et posologie : Azithromycine, Chloroquine, Hydroxychloroquine.
- effets indésirables : Azithromycine, Chloroquine, Hydroxychloroquine, Troubles mentaux.
- induit chimiquement : Syndrome du QT long.
- traitement médicamenteux : Infections à coronavirus, Pneumopathie virale.
- épidémiologie : Infections à coronavirus, Pneumopathie virale, Syndrome du QT long.
- Association de médicaments, Facteurs de risque, Humains, Pandémies.
English descriptors
- KwdEn :
- Azithromycin (administration & dosage), Azithromycin (adverse effects), Chloroquine (administration & dosage), Chloroquine (adverse effects), Coronavirus Infections (drug therapy), Coronavirus Infections (epidemiology), Drug Therapy, Combination (MeSH), Humans (MeSH), Hydroxychloroquine (administration & dosage), Hydroxychloroquine (adverse effects), Long QT Syndrome (chemically induced), Long QT Syndrome (epidemiology), Mental Disorders (complications), Pandemics (MeSH), Pneumonia, Viral (drug therapy), Pneumonia, Viral (epidemiology), Risk Factors (MeSH).
- MESH :
- chemical , administration & dosage : Azithromycin, Chloroquine, Hydroxychloroquine.
- chemical , adverse effects : Azithromycin, Chloroquine, Hydroxychloroquine.
- chemically induced : Long QT Syndrome.
- complications : Mental Disorders.
- drug therapy : Coronavirus Infections, Pneumonia, Viral.
- epidemiology : Coronavirus Infections, Long QT Syndrome, Pneumonia, Viral.
- Drug Therapy, Combination, Humans, Pandemics, Risk Factors.
DOI: 10.1111/bcp.14335
PubMed: 32350872
PubMed Central: PMC7256125
Affiliations:
- France
- Alsace (région administrative), Centre-Val de Loire, Grand Est, Lorraine (région), Région Centre
- Nancy, Strasbourg, Tours
- Université de Strasbourg, Université de Tours
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">COVID-19 and (hydroxy)chloroquine-azithromycin combination: Should we take the risk for our patients?</title><author><name sortKey="Javelot, Herve" sort="Javelot, Herve" uniqKey="Javelot H" first="Hervé" last="Javelot">Hervé Javelot</name><affiliation wicri:level="1"><nlm:affiliation>Clinical Pharmacy Service, EPSAN, Brumath, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Clinical Pharmacy Service, EPSAN, Brumath</wicri:regionArea><wicri:noRegion>Brumath</wicri:noRegion><wicri:noRegion>Brumath</wicri:noRegion></affiliation><affiliation wicri:level="4"><nlm:affiliation>Laboratoire de Toxicologie et Pharmacologie Neuro Cardiovasculaire, Université de Strasbourg, Strasbourg, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Laboratoire de Toxicologie et Pharmacologie Neuro Cardiovasculaire, Université de Strasbourg, Strasbourg</wicri:regionArea><placeName><region type="region">Grand Est</region><region type="old region">Alsace (région administrative)</region><settlement type="city">Strasbourg</settlement></placeName><orgName type="university">Université de Strasbourg</orgName></affiliation></author><author><name sortKey="El Hage, Wissam" sort="El Hage, Wissam" uniqKey="El Hage W" first="Wissam" last="El-Hage">Wissam El-Hage</name><affiliation wicri:level="4"><nlm:affiliation>UMR 1253, iBrain, Université de Tours, CHRU de Tours, INSERM, Tours, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>UMR 1253, iBrain, Université de Tours, CHRU de Tours, INSERM, Tours</wicri:regionArea><placeName><region type="region">Centre-Val de Loire</region><region type="old region">Région Centre</region><settlement type="city">Tours</settlement></placeName><orgName type="university">Université de Tours</orgName></affiliation><affiliation wicri:level="3"><nlm:affiliation>CentreExpert Dépression Résistante, Fondation FondaMental, Tours, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>CentreExpert Dépression Résistante, Fondation FondaMental, Tours</wicri:regionArea><placeName><region type="region">Centre-Val de Loire</region><region type="old region">Région Centre</region><settlement type="city">Tours</settlement></placeName></affiliation></author><author><name sortKey="Meyer, Guillaume" sort="Meyer, Guillaume" uniqKey="Meyer G" first="Guillaume" last="Meyer">Guillaume Meyer</name><affiliation wicri:level="1"><nlm:affiliation>Clinical Pharmacy Service, EPSAN, Brumath, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Clinical Pharmacy Service, EPSAN, Brumath</wicri:regionArea><wicri:noRegion>Brumath</wicri:noRegion><wicri:noRegion>Brumath</wicri:noRegion></affiliation><affiliation wicri:level="3"><nlm:affiliation>Clinical Pharmacy Service, CHU, Strasbourg, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Clinical Pharmacy Service, CHU, Strasbourg</wicri:regionArea><placeName><region type="region">Grand Est</region><region type="old region">Alsace (région administrative)</region><settlement type="city">Strasbourg</settlement></placeName></affiliation></author><author><name sortKey="Becker, Guillaume" sort="Becker, Guillaume" uniqKey="Becker G" first="Guillaume" last="Becker">Guillaume Becker</name><affiliation wicri:level="4"><nlm:affiliation>Laboratoire de Toxicologie et Pharmacologie Neuro Cardiovasculaire, Université de Strasbourg, Strasbourg, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Laboratoire de Toxicologie et Pharmacologie Neuro Cardiovasculaire, Université de Strasbourg, Strasbourg</wicri:regionArea><placeName><region type="region">Grand Est</region><region type="old region">Alsace (région administrative)</region><settlement type="city">Strasbourg</settlement></placeName><orgName type="university">Université de Strasbourg</orgName></affiliation></author><author><name sortKey="Michel, Bruno" sort="Michel, Bruno" uniqKey="Michel B" first="Bruno" last="Michel">Bruno Michel</name><affiliation wicri:level="4"><nlm:affiliation>Laboratoire de Toxicologie et Pharmacologie Neuro Cardiovasculaire, Université de Strasbourg, Strasbourg, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Laboratoire de Toxicologie et Pharmacologie Neuro Cardiovasculaire, Université de Strasbourg, Strasbourg</wicri:regionArea><placeName><region type="region">Grand Est</region><region type="old region">Alsace (région administrative)</region><settlement type="city">Strasbourg</settlement></placeName><orgName type="university">Université de Strasbourg</orgName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Clinical Pharmacy Service, CHU, Strasbourg, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Clinical Pharmacy Service, CHU, Strasbourg</wicri:regionArea><placeName><region type="region">Grand Est</region><region type="old region">Alsace (région administrative)</region><settlement type="city">Strasbourg</settlement></placeName></affiliation></author><author><name sortKey="Hingray, Coraline" sort="Hingray, Coraline" uniqKey="Hingray C" first="Coraline" last="Hingray">Coraline Hingray</name><affiliation wicri:level="1"><nlm:affiliation>Pôle Hospitalo-Universitaire de Psychiatrie d'Adultes du Grand Nancy, Centre Psychothérapique de Nancy, Laxou, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Pôle Hospitalo-Universitaire de Psychiatrie d'Adultes du Grand Nancy, Centre Psychothérapique de Nancy, Laxou</wicri:regionArea><wicri:noRegion>Laxou</wicri:noRegion><wicri:noRegion>Laxou</wicri:noRegion></affiliation><affiliation wicri:level="3"><nlm:affiliation>CHU de Nancy, Département de Neurologie, Nancy, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>CHU de Nancy, Département de Neurologie, Nancy</wicri:regionArea><placeName><region type="region">Grand Est</region><region type="old region">Lorraine (région)</region><settlement type="city">Nancy</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32350872</idno><idno type="pmid">32350872</idno><idno type="doi">10.1111/bcp.14335</idno><idno type="pmc">PMC7256125</idno><idno type="wicri:Area/Main/Corpus">001527</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001527</idno><idno type="wicri:Area/Main/Curation">001527</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001527</idno><idno type="wicri:Area/Main/Exploration">001527</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">COVID-19 and (hydroxy)chloroquine-azithromycin combination: Should we take the risk for our patients?</title><author><name sortKey="Javelot, Herve" sort="Javelot, Herve" uniqKey="Javelot H" first="Hervé" last="Javelot">Hervé Javelot</name><affiliation wicri:level="1"><nlm:affiliation>Clinical Pharmacy Service, EPSAN, Brumath, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Clinical Pharmacy Service, EPSAN, Brumath</wicri:regionArea><wicri:noRegion>Brumath</wicri:noRegion><wicri:noRegion>Brumath</wicri:noRegion></affiliation><affiliation wicri:level="4"><nlm:affiliation>Laboratoire de Toxicologie et Pharmacologie Neuro Cardiovasculaire, Université de Strasbourg, Strasbourg, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Laboratoire de Toxicologie et Pharmacologie Neuro Cardiovasculaire, Université de Strasbourg, Strasbourg</wicri:regionArea><placeName><region type="region">Grand Est</region><region type="old region">Alsace (région administrative)</region><settlement type="city">Strasbourg</settlement></placeName><orgName type="university">Université de Strasbourg</orgName></affiliation></author><author><name sortKey="El Hage, Wissam" sort="El Hage, Wissam" uniqKey="El Hage W" first="Wissam" last="El-Hage">Wissam El-Hage</name><affiliation wicri:level="4"><nlm:affiliation>UMR 1253, iBrain, Université de Tours, CHRU de Tours, INSERM, Tours, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>UMR 1253, iBrain, Université de Tours, CHRU de Tours, INSERM, Tours</wicri:regionArea><placeName><region type="region">Centre-Val de Loire</region><region type="old region">Région Centre</region><settlement type="city">Tours</settlement></placeName><orgName type="university">Université de Tours</orgName></affiliation><affiliation wicri:level="3"><nlm:affiliation>CentreExpert Dépression Résistante, Fondation FondaMental, Tours, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>CentreExpert Dépression Résistante, Fondation FondaMental, Tours</wicri:regionArea><placeName><region type="region">Centre-Val de Loire</region><region type="old region">Région Centre</region><settlement type="city">Tours</settlement></placeName></affiliation></author><author><name sortKey="Meyer, Guillaume" sort="Meyer, Guillaume" uniqKey="Meyer G" first="Guillaume" last="Meyer">Guillaume Meyer</name><affiliation wicri:level="1"><nlm:affiliation>Clinical Pharmacy Service, EPSAN, Brumath, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Clinical Pharmacy Service, EPSAN, Brumath</wicri:regionArea><wicri:noRegion>Brumath</wicri:noRegion><wicri:noRegion>Brumath</wicri:noRegion></affiliation><affiliation wicri:level="3"><nlm:affiliation>Clinical Pharmacy Service, CHU, Strasbourg, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Clinical Pharmacy Service, CHU, Strasbourg</wicri:regionArea><placeName><region type="region">Grand Est</region><region type="old region">Alsace (région administrative)</region><settlement type="city">Strasbourg</settlement></placeName></affiliation></author><author><name sortKey="Becker, Guillaume" sort="Becker, Guillaume" uniqKey="Becker G" first="Guillaume" last="Becker">Guillaume Becker</name><affiliation wicri:level="4"><nlm:affiliation>Laboratoire de Toxicologie et Pharmacologie Neuro Cardiovasculaire, Université de Strasbourg, Strasbourg, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Laboratoire de Toxicologie et Pharmacologie Neuro Cardiovasculaire, Université de Strasbourg, Strasbourg</wicri:regionArea><placeName><region type="region">Grand Est</region><region type="old region">Alsace (région administrative)</region><settlement type="city">Strasbourg</settlement></placeName><orgName type="university">Université de Strasbourg</orgName></affiliation></author><author><name sortKey="Michel, Bruno" sort="Michel, Bruno" uniqKey="Michel B" first="Bruno" last="Michel">Bruno Michel</name><affiliation wicri:level="4"><nlm:affiliation>Laboratoire de Toxicologie et Pharmacologie Neuro Cardiovasculaire, Université de Strasbourg, Strasbourg, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Laboratoire de Toxicologie et Pharmacologie Neuro Cardiovasculaire, Université de Strasbourg, Strasbourg</wicri:regionArea><placeName><region type="region">Grand Est</region><region type="old region">Alsace (région administrative)</region><settlement type="city">Strasbourg</settlement></placeName><orgName type="university">Université de Strasbourg</orgName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Clinical Pharmacy Service, CHU, Strasbourg, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Clinical Pharmacy Service, CHU, Strasbourg</wicri:regionArea><placeName><region type="region">Grand Est</region><region type="old region">Alsace (région administrative)</region><settlement type="city">Strasbourg</settlement></placeName></affiliation></author><author><name sortKey="Hingray, Coraline" sort="Hingray, Coraline" uniqKey="Hingray C" first="Coraline" last="Hingray">Coraline Hingray</name><affiliation wicri:level="1"><nlm:affiliation>Pôle Hospitalo-Universitaire de Psychiatrie d'Adultes du Grand Nancy, Centre Psychothérapique de Nancy, Laxou, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Pôle Hospitalo-Universitaire de Psychiatrie d'Adultes du Grand Nancy, Centre Psychothérapique de Nancy, Laxou</wicri:regionArea><wicri:noRegion>Laxou</wicri:noRegion><wicri:noRegion>Laxou</wicri:noRegion></affiliation><affiliation wicri:level="3"><nlm:affiliation>CHU de Nancy, Département de Neurologie, Nancy, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>CHU de Nancy, Département de Neurologie, Nancy</wicri:regionArea><placeName><region type="region">Grand Est</region><region type="old region">Lorraine (région)</region><settlement type="city">Nancy</settlement></placeName></affiliation></author></analytic><series><title level="j">British journal of clinical pharmacology</title><idno type="eISSN">1365-2125</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Azithromycin (administration & dosage)</term><term>Azithromycin (adverse effects)</term><term>Chloroquine (administration & dosage)</term><term>Chloroquine (adverse effects)</term><term>Coronavirus Infections (drug therapy)</term><term>Coronavirus Infections (epidemiology)</term><term>Drug Therapy, Combination (MeSH)</term><term>Humans (MeSH)</term><term>Hydroxychloroquine (administration & dosage)</term><term>Hydroxychloroquine (adverse effects)</term><term>Long QT Syndrome (chemically induced)</term><term>Long QT Syndrome (epidemiology)</term><term>Mental Disorders (complications)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (drug therapy)</term><term>Pneumonia, Viral (epidemiology)</term><term>Risk Factors (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Association de médicaments (MeSH)</term><term>Azithromycine (administration et posologie)</term><term>Azithromycine (effets indésirables)</term><term>Chloroquine (administration et posologie)</term><term>Chloroquine (effets indésirables)</term><term>Facteurs de risque (MeSH)</term><term>Humains (MeSH)</term><term>Hydroxychloroquine (administration et posologie)</term><term>Hydroxychloroquine (effets indésirables)</term><term>Infections à coronavirus (traitement médicamenteux)</term><term>Infections à coronavirus (épidémiologie)</term><term>Pandémies (MeSH)</term><term>Pneumopathie virale (traitement médicamenteux)</term><term>Pneumopathie virale (épidémiologie)</term><term>Syndrome du QT long (induit chimiquement)</term><term>Syndrome du QT long (épidémiologie)</term><term>Troubles mentaux (complications)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Azithromycin</term><term>Chloroquine</term><term>Hydroxychloroquine</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Azithromycin</term><term>Chloroquine</term><term>Hydroxychloroquine</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Azithromycine</term><term>Chloroquine</term><term>Hydroxychloroquine</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Long QT Syndrome</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Mental Disorders</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Azithromycine</term><term>Chloroquine</term><term>Hydroxychloroquine</term><term>Troubles mentaux</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term><term>Long QT Syndrome</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="induit chimiquement" xml:lang="fr"><term>Syndrome du QT long</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term><term>Syndrome du QT long</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Drug Therapy, Combination</term><term>Humans</term><term>Pandemics</term><term>Risk Factors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Association de médicaments</term><term>Facteurs de risque</term><term>Humains</term><term>Pandémies</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32350872</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>09</Day></DateCompleted><DateRevised><Year>2020</Year><Month>06</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2125</ISSN><JournalIssue CitedMedium="Internet"><Volume>86</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Month>06</Month></PubDate></JournalIssue><Title>British journal of clinical pharmacology</Title><ISOAbbreviation>Br J Clin Pharmacol</ISOAbbreviation></Journal><ArticleTitle>COVID-19 and (hydroxy)chloroquine-azithromycin combination: Should we take the risk for our patients?</ArticleTitle><Pagination><MedlinePgn>1176-1177</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/bcp.14335</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Javelot</LastName><ForeName>Hervé</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-2682-7677</Identifier><AffiliationInfo><Affiliation>Clinical Pharmacy Service, EPSAN, Brumath, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratoire de Toxicologie et Pharmacologie Neuro Cardiovasculaire, Université de Strasbourg, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Hage</LastName><ForeName>Wissam</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>UMR 1253, iBrain, Université de Tours, CHRU de Tours, INSERM, Tours, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CentreExpert Dépression Résistante, Fondation FondaMental, Tours, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meyer</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Clinical Pharmacy Service, EPSAN, Brumath, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Pharmacy Service, CHU, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Becker</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-2710-0960</Identifier><AffiliationInfo><Affiliation>Laboratoire de Toxicologie et Pharmacologie Neuro Cardiovasculaire, Université de Strasbourg, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Michel</LastName><ForeName>Bruno</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Laboratoire de Toxicologie et Pharmacologie Neuro Cardiovasculaire, Université de Strasbourg, Strasbourg, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Pharmacy Service, CHU, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hingray</LastName><ForeName>Coraline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Pôle Hospitalo-Universitaire de Psychiatrie d'Adultes du Grand Nancy, Centre Psychothérapique de Nancy, Laxou, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CHU de Nancy, Département de Neurologie, Nancy, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Clin Pharmacol</MedlineTA><NlmUniqueID>7503323</NlmUniqueID><ISSNLinking>0306-5251</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber><NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance></Chemical><Chemical><RegistryNumber>83905-01-5</RegistryNumber><NameOfSubstance UI="D017963">Azithromycin</NameOfSubstance></Chemical><Chemical><RegistryNumber>886U3H6UFF</RegistryNumber><NameOfSubstance UI="D002738">Chloroquine</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017963" MajorTopicYN="N">Azithromycin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002738" MajorTopicYN="N">Chloroquine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008133" MajorTopicYN="N">Long QT Syndrome</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001523" MajorTopicYN="N">Mental Disorders</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">COVID-19</Keyword><Keyword MajorTopicYN="Y">QT prolongation</Keyword><Keyword MajorTopicYN="Y">azithromycin</Keyword><Keyword MajorTopicYN="Y">hydroxychloroquine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>04</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>04</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32350872</ArticleId><ArticleId IdType="doi">10.1111/bcp.14335</ArticleId><ArticleId IdType="pmc">PMC7256125</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lancet Psychiatry. 2020 Apr;7(4):e21</Citation><ArticleIdList><ArticleId IdType="pubmed">32199510</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Antimicrob Agents. 2020 May;55(5):105938</Citation><ArticleIdList><ArticleId IdType="pubmed">32171740</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Clin Pharm. 2017 Feb;39(1):16-25</Citation><ArticleIdList><ArticleId IdType="pubmed">28012118</ArticleId></ArticleIdList></Reference><Reference><Citation>Ther Adv Infect Dis. 2013 Oct;1(5):155-65</Citation><ArticleIdList><ArticleId IdType="pubmed">25165550</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Cardiovasc Med. 2018 Feb;28(2):94-99</Citation><ArticleIdList><ArticleId IdType="pubmed">28801207</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>France</li></country><region><li>Alsace (région administrative)</li><li>Centre-Val de Loire</li><li>Grand Est</li><li>Lorraine (région)</li><li>Région Centre</li></region><settlement><li>Nancy</li><li>Strasbourg</li><li>Tours</li></settlement><orgName><li>Université de Strasbourg</li><li>Université de Tours</li></orgName></list><tree><country name="France"><noRegion><name sortKey="Javelot, Herve" sort="Javelot, Herve" uniqKey="Javelot H" first="Hervé" last="Javelot">Hervé Javelot</name></noRegion><name sortKey="Becker, Guillaume" sort="Becker, Guillaume" uniqKey="Becker G" first="Guillaume" last="Becker">Guillaume Becker</name><name sortKey="El Hage, Wissam" sort="El Hage, Wissam" uniqKey="El Hage W" first="Wissam" last="El-Hage">Wissam El-Hage</name><name sortKey="El Hage, Wissam" sort="El Hage, Wissam" uniqKey="El Hage W" first="Wissam" last="El-Hage">Wissam El-Hage</name><name sortKey="Hingray, Coraline" sort="Hingray, Coraline" uniqKey="Hingray C" first="Coraline" last="Hingray">Coraline Hingray</name><name sortKey="Hingray, Coraline" sort="Hingray, Coraline" uniqKey="Hingray C" first="Coraline" last="Hingray">Coraline Hingray</name><name sortKey="Javelot, Herve" sort="Javelot, Herve" uniqKey="Javelot H" first="Hervé" last="Javelot">Hervé Javelot</name><name sortKey="Meyer, Guillaume" sort="Meyer, Guillaume" uniqKey="Meyer G" first="Guillaume" last="Meyer">Guillaume Meyer</name><name sortKey="Meyer, Guillaume" sort="Meyer, Guillaume" uniqKey="Meyer G" first="Guillaume" last="Meyer">Guillaume Meyer</name><name sortKey="Michel, Bruno" sort="Michel, Bruno" uniqKey="Michel B" first="Bruno" last="Michel">Bruno Michel</name><name sortKey="Michel, Bruno" sort="Michel, Bruno" uniqKey="Michel B" first="Bruno" last="Michel">Bruno Michel</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001579 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001579 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidFranceV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32350872
|texte= COVID-19 and (hydroxy)chloroquine-azithromycin combination: Should we take the risk for our patients?
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32350872" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidFranceV1
| This area was generated with Dilib version V0.6.37. |  |